| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/01/2005 | US20050265954 Novel association, a method of its preparation and its uses |
| 12/01/2005 | US20050265937 Systems and methods for changing eye color appearance |
| 12/01/2005 | US20050265926 Methods and reagents for improving localization of treatment and visualization ligands to sites in a mammal |
| 12/01/2005 | US20050265925 Conjugates containing a lipid or a hydrophilic polymer, linked to a ligand derived from an amine- or hydroxyl-containing compound, such as a drug or protein, are stable under conditions of storage, and are cleavable under mild thiolytic conditions to regenerate the ligand |
| 12/01/2005 | US20050265923 Embolus therapy using insoluble microparticles or vesicles containing contrast agents |
| 12/01/2005 | US20050265922 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 12/01/2005 | CA2564076A1 Chemical linkers and conjugates thereof |
| 12/01/2005 | CA2562482A1 Novel gene disruptions, compositions and methods relating thereto |
| 11/30/2005 | EP1600153A1 Slow-release pharmaceutical composition allowing to monitor drug release |
| 11/30/2005 | EP1599726A2 Selective modulation of tlr-mediated biological activity |
| 11/30/2005 | EP1599226A1 A method of diagnosis and treatment |
| 11/30/2005 | EP1418808B1 Imaging marker transgenes |
| 11/30/2005 | EP1380295A4 Photosensitiser and method for production thereof |
| 11/30/2005 | EP1301605B1 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 11/30/2005 | EP1109909B1 Grf analogs with increased biological potency |
| 11/30/2005 | EP0831933B1 Use of emulsions comprising lipid encapsulated liquid fluorocarbons for in vivo targeted diagnostic procedures |
| 11/30/2005 | CN1701817A Contrast agent for combined modality imaging and methods and systems thereof |
| 11/30/2005 | CN1229357C Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-l,4,7,10-tetraazacyclododecane, prodn. and use thereof |
| 11/30/2005 | CN1229078C Medical optical imaging scanner using multiple wavelength simultaneous data acquisition for breast imaging |
| 11/29/2005 | US6969765 Photosensitizer and method for production thereof |
| 11/29/2005 | US6969507 Imaging sexual response |
| 11/24/2005 | WO2005111234A2 Methods of using zc1 and zc3 kinase substrate phosphorylation as biomarkers |
| 11/24/2005 | WO2005110545A2 Biomolecular contrast agents for therapy success and dose monitoring in radiation therapy with proton or ion beams |
| 11/24/2005 | WO2005110497A1 Imaging of tumors and metastases using a gelatinase targeting peptide comprising the structure ctthwgftlc. |
| 11/24/2005 | WO2005110496A2 Biomolecular contrast agents for therapy optimization in radiation therapy with proton or ion beams |
| 11/24/2005 | WO2005110495A1 Biomolecular contrast agents for therapy control in radiation therapy with proton or ion beams |
| 11/24/2005 | WO2005110489A2 Nucleic acid aptamers conjugated to high molecular weight steric groups |
| 11/24/2005 | WO2005110397A1 Treatment of myopia |
| 11/24/2005 | WO2005110207A1 Optical sensor for in vivo detection of analyte |
| 11/24/2005 | WO2005086639A3 Improved efficacy and safety of targeted particulate agents with decoy systems |
| 11/24/2005 | WO2005077343A9 Novel drugs and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 11/24/2005 | WO2005016401A3 Improved intra-dermal delivery of biologically active agents |
| 11/24/2005 | US20050262580 Transgenic mouse with a targeted deletion of Elovl4 gene |
| 11/24/2005 | US20050261472 Binding moieties for fibrin |
| 11/24/2005 | US20050260651 Enhanced biologically active conjugates |
| 11/24/2005 | US20050260224 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 11/24/2005 | US20050260189 Microbubble compositions, and methods for preparing and using same |
| 11/24/2005 | US20050260153 Facilitation of iontophoresis using charged moieties |
| 11/24/2005 | US20050260137 Contrast agents for magnetic resonance imaging |
| 11/24/2005 | US20050260136 Topical immune competency diagnostic compositions and methods of use |
| 11/24/2005 | US20050260135 High throughput pharmaceutical screening using drosophila |
| 11/24/2005 | US20050260129 Contrast agents used in various embodiments may be any organic or semi-organic compounds which have the desired effect of affinity to certain target tissues/cells to either bind with them or react with them or react with metabolic products of the target; dosage monitoring and therapy success mechanism |
| 11/24/2005 | US20050260128 Low toxicity carborane-containing 5, 10, 15, 20-tetraphenylporphyrin compounds; use in the treatment, visualization, and diagnosis of tumors such as in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT) |
| 11/24/2005 | US20050260127 Diagnostic compounds comprising a scaffold coupled to a signal entity for medical imaging diagnostic |
| 11/24/2005 | US20050260125 e.g. (N-(2-chloro-5-(methylthio)phenyl)-N'-(3-methylthio)phenyl)-N'-[N-methyl-11C]-methylguanidine; in vivo diagnostic or imaging method such as PET for central nervous system (N-methyl-D-aspartate) receptors; stroke, brain or spinal chord trauma, epilepsy, Alzheimer's, and Huntington's diseases |
| 11/24/2005 | US20050259779 Biomolecular contrast agents for therapy optimization in radiation therapy with proton or ion beams |
| 11/24/2005 | CA2567064A1 Optical sensor for in vivo detection of analyte |
| 11/24/2005 | CA2562948A1 Enhanced biologically active conjugates |
| 11/23/2005 | EP1598082A1 Contrast medium for mri |
| 11/23/2005 | EP1596659A2 Progenitor cells and methods of using same |
| 11/23/2005 | EP1423151A4 Light-stabilized $i(in vivo) stain composition and method of manufacture |
| 11/23/2005 | EP1263802B1 Hydrogel biomedical articles |
| 11/23/2005 | CN1698909A Lymph dye making silicon dioxide microparticle as supporter and its preparation method |
| 11/23/2005 | CN1698908A Micro nano grade dye for marking sentinel node, its preparation method and application |
| 11/23/2005 | CN1698907A Duplication method of chmice acute hyperuricemia model |
| 11/23/2005 | CN1698906A Duplication method of rat acute or persistent hyperuricemia model |
| 11/23/2005 | CN1698905A Method for constructing T lymphocyte immunologic function reconstruction model |
| 11/22/2005 | US6967015 undesired binding of cancer-selective dyes to proteins in the extracellular matrix, which may lead to false positives, is reduced by applying before application of the dye, a solution of a non-toxic amphiphilic protein in a solvent |
| 11/17/2005 | WO2005108379A1 Macrocycle-substituted trimer halogen-benzol derivatives |
| 11/17/2005 | WO2005107820A1 Compositions and methods for enhancing contrast in imaging |
| 11/17/2005 | WO2005107818A2 Nanoparticles and their use for multifunctional bioimaging |
| 11/17/2005 | WO2005107776A1 METHOD OF ADMINISTERING PORCINE B-DOMAINLESS fVIII |
| 11/17/2005 | WO2005107387A2 Targeting of radioimagining and radiotherapy agents |
| 11/17/2005 | WO2005041883A3 Reduction of unintended use of transdermal devices |
| 11/17/2005 | US20050256360 Methods of enhancing radiation effects with metal nanoparticles |
| 11/17/2005 | US20050255451 Toll-like receptor 9 modulators |
| 11/17/2005 | US20050255317 Polymeric marker with high radiopacity for use in medical devices |
| 11/17/2005 | US20050255045 Surgical marking composition and method |
| 11/17/2005 | US20050255044 Contrast agent for combined modality imaging and methods and systems thereof |
| 11/17/2005 | US20050255043 Bacteriophage imaging of inflammation |
| 11/17/2005 | US20050255038 Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof |
| 11/16/2005 | EP1595550A1 Selective retention of anti-cancer therapeutics in tumour cells through intra-cellular reaction with heat shock proteins |
| 11/16/2005 | EP1594875A1 Porphyrin derivatives |
| 11/16/2005 | EP1594851A1 Trimeric macrocyclically substituted benzene derivatives |
| 11/16/2005 | EP1594551A2 In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes |
| 11/16/2005 | EP1594550A2 Chelating agents with lipophilic carriers |
| 11/16/2005 | EP1594542A2 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 11/16/2005 | EP1594467A1 Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
| 11/16/2005 | EP1594427A2 Resorbable radiopaque markers and related medical implants |
| 11/16/2005 | EP1146857B1 Materials and methods for making improved micelle compositions |
| 11/16/2005 | CN1695741A Method for making rat possess pathology features of acute hyperlipemia |
| 11/16/2005 | CN1227263C Peptide diagnostic and therapeutic agent for autoimmune diseases |
| 11/15/2005 | CA2111512C 3,5-substituted aminobenzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 11/10/2005 | WO2005106476A2 Method for diagnosing infectious diseases |
| 11/10/2005 | WO2005106367A2 Method and apparatus for accumulating hyperpolarized xenon |
| 11/10/2005 | WO2005105838A2 Ion channel |
| 11/10/2005 | WO2005105159A2 Contrast agents for myocardial perfusion imaging |
| 11/10/2005 | WO2005105154A1 Polymer conjugate releasable under mild thiolytic conditions |
| 11/10/2005 | WO2005105035A2 Targeted nanoparticles for drug delivery |
| 11/10/2005 | WO2005104836A2 Drosophila models for diseases affecting learning and memory |
| 11/10/2005 | WO2005104833A1 Method of constructing animal model suffering from left ventricular diastolic disorder for examining heart failure and method of examining remedy for heart failure caused by left ventricular diastolic failure with the use of the animal model |
| 11/10/2005 | WO2005104696A2 Non-gmo metal amino acid chelates and non-gmo metal amino acid chelate-containing compositions |
| 11/10/2005 | WO2005016231A3 Agents and methods for treatment of disease by oligosaccharide targeting agents |
| 11/10/2005 | WO2005009222A3 Method of determining sperm capacitation |
| 11/10/2005 | US20050251869 Animal model for raising HDL-cholesterol with niacin |
| 11/10/2005 | US20050250696 Truncated soluble tumor necrosis factor type-I and type-II receptors |
| 11/10/2005 | US20050250672 Using antihyperplastic agent; diffusion through capillaries; imaging veins, arteries; side effect reduction; antitumor agents |
| 11/10/2005 | US20050249808 NSAIDs compositions containing tartaric acid |
| 11/10/2005 | US20050249672 Temporary tattoo for testing the sensitivity of skin to chemicals |
| 11/10/2005 | US20050249670 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |